Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03225703
Other study ID # R16-P149
Secondary ID
Status Recruiting
Phase N/A
First received April 5, 2017
Last updated July 18, 2017
Start date January 2017
Est. completion date January 2019

Study information

Verified date July 2017
Source Loughborough University
Contact Christopher M Hartley, MSC
Email c.hartley@lboro.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Osteoarthritis (OA) and osteoporosis (OP) affect large numbers of the population. Around 8 million people in the UK are affected by OA and over 300,000 people present with fragility fractures in the UK each year. High impact exercise has been shown to improve markers of bone health but the effect of this exercise on the cartilage is less well understood. A six month, one leg, exercise program based on hopping will be carried out by a group of post-menopausal women. Post-menopausal women are particularly at risk from OP and the research should give information on the feasibility of this type of exercise program in this age group and the effect on cartilage. Participants will be aged between 55 and 70 (at least five years post menopause) with no conditions that would limit their ability to complete the exercise program.

To assess changes in participants' cartilage and bone properties they will be asked to attend several meetings at Loughborough University. Before and after the exercise program participants will have bone density scans and MRI scans of the knee joint. A subset (n=4) will undergo high resolution bone scans that can demonstrate changes in bone structure. The intervention is a home based exercise programme lasting approximately 10 minutes per day. Initially this will be individualised to each participant with the end goal being daily exercise sessions. The programme will last for six months with supervised sessions offered throughout the trial. Using an intervention affecting just one leg will allow the research team to use the other leg as a control.

The research team hypothesise that in a population of post-menopausal women, a six month, unilateral exercise intervention will improve bone mineral density at the proximal femur with no negative effects on articular cartilage.


Description:

The research is a 6 month, intervention study of unilateral (single limb) exercise with the changes in a randomly chosen exercise leg being compared to those in the other (control) leg.

Potential participants (women aged 55-70) will be approached via existing links in the community, at local community centres, through local media, posters and flyers. After initial contact to determine whether they meet the inclusion/exclusion criteria they will be invited to join the study and sent the participant information sheet (PIS). If they then wish to aid in the research they will be invited to a first meeting at Loughborough University.

At the initial meeting the participant can further discuss the project and PIS with the research team. If they fully understand the project and are happy to take part they will be invited to sign the informed consent form. At this stage each participant will be anonymised using a project code. Screening and baseline measurements will then be taken.

Screening questionnaires will be taken following consent to the study. These include a demographic questionnaire, health screen questionnaire, calcium intake questionnaire, physical activity readiness questionnaire (PAR-Q) and bone physical activity questionnaire (BPAQ).

Dual X-ray Absorptiometry (DXA) scans of the whole body, anterior-posterior (AP) spine and dual femur will be taken for each participant to give baseline measurements of bone mineral density.Standard positioning procedures for the measurement being taken will be utilised to allow the calculation of the T-score.

Functional tests will be performed to investigate hopping and balance ability. Unilateral balance will be analysed by measuring postural sway using a force platform. Participants will be asked to balance on one leg for up to 30 seconds. Amplitude of displacement will be calculated, this is the distance between the maximum and minimum centre of pressure (COP) in both directions. COP path length is the total distance travelled and will be calculated and divided by the trial time to give the COP velocity.

Maximal hop height will be measured by recording the vertical displacement of a marker placed on the lumbar spine of each participant whilst conducting a maximal hop. This will be repeated for each leg. The ground reaction force (GRF) of the maximal hop will be recorded using a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform a counter movement, maximal hop using their arms to help with propulsion and ensure maximal hop height. After one or two familiarisation attempts the participant will be asked to complete three maximal hops. Allowing for repeats if they do not land fully on the force platform. The peak GRF recorded from these three attempts will be used in the final analysis.

Ground reaction forces during a set of ten hops, which is the end goal of the exercise programme, will be recorded on a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform ten counter movement hops using their arms to help with propulsion if able. At the baseline measurements participants will be asked to perform ten hops to the best of their ability, with a rigid support available for them to lean on

A second appointment will be arranged to acquire baseline MRI scans of each knee joint. This will involve the safety checks, conversation with the radiographers and scan times of up to one hour.

Following the MRI scans the exercise leg will be randomly assigned using opaque envelopes. Each envelope will contain a note saying either 'left leg' or 'right leg'. The envelopes will be split into smaller subgroups of eight for minimisation. This will remove the possibility of the first half of volunteers choosing the same leg and removing the randomisation effect on the second half. Participants will be presented with a training diary and instructions on how to complete the exercise programme over six months. The first day of exercise will be completed with the research team at this appointment and the intervention considered started. This second meeting should last for approximately 90 minutes.

The required exercise lasts for no longer than 10 minutes each session and can be performed at home. The intervention will be personalised to the individual's ability and the frequency of the exercise will steadily increase as the participant improves, until the exercise is completed daily. Regular group sessions at Loughborough University will be offered to all participants. The exercise time will remain at ten minutes but the session will be longer, allowing for discussion and check-ups with participants. These will be weekly sessions for the first two months and then once a month for the remaining time.

Follow up measurements will take place six months after the commencement of the exercise programme. Repeat DXA, MRI and functional outcome tests will be carried out on all participants, following the same protocol as at baseline. Again this will occur over two meetings at Loughborough University.

A subset (n=4) will undergo high resolution bone scans (HR-pQCT) that can demonstrate changes in bone structure. This measurement will be taken at the distal tibia and lasts around three minutes per leg. Measurements will be taken pre and post the six month exercise intervention.

Descriptive statistics will be calculated to give information on mean values and variation (standard deviation) of the cohort. This will include age, height, body mass, BMI and time since last menstruation.

Using Levene's test when comparing the exercise to control leg and Mauchly's test of sphericity to compare from baseline to end of study, the variance of the data will be analysed. Normal distribution will be analysed using Shapiro-Wilks test and visual examination of Q-Q plot. If variance is shown to be homogenous and distribution normal within the population then a repeated measures analysis of variance (RM-ANOVA)will be used to detect any significant differences between leg (exercise versus control, time (baseline versus post-intervention) or leg x time interaction in the outcome variable described previously. If any of the outcome measures do not meet the assumptions to conduct parametric tests i.e. ANOVA then Kruskal-Wallis H test will be used to detect any significant change in differences.


Recruitment information / eligibility

Status Recruiting
Enrollment 32
Est. completion date January 2019
Est. primary completion date June 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 55 Years to 70 Years
Eligibility Inclusion Criteria:

- Post-menopausal - at least 12 months since last menstruation and/or hysterectomy, oophorectomy or hormonal contraceptive use

Exclusion Criteria:

- Existing knee, hip or back injury.

- Any medical conditions or injuries which exclude participation in an exercise intervention e.g. heart conditions, hypertension

- BMI > 30 kg/m2

- Participation in a study involving ionising radiation in the previous 12 months.

- Exercise involving ground reaction forces greater than that of jogging more than once a week.

- Contraindications to MRI or DXA

- Osteoporotic (FRAX score requiring the participant is advised to seek treatment)

- Medication affecting bone metabolism or density

Study Design


Intervention

Behavioral:
Hopping
A unilateral, hopping based exercise programme lasting six months.

Locations

Country Name City State
United Kingdom Loughborough University Loughborough Leicestershire

Sponsors (1)

Lead Sponsor Collaborator
Loughborough University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in T2 Relaxation Time (ms) T2 mapping is an indicator of the water content in cartilage, with longer relaxation times a marker of cartilage degeneration 6 months (pre and post intervention)
Secondary Change in Femoral neck bone mineral density (g/cm2) 6 months (pre and post intervention)
Secondary Change in Femoral neck bone mineral content (g) 6 months (pre and post intervention)
Secondary Change in Spine bone mineral density (g/cm2) 6 months (pre and post intervention)
Secondary Change in Spine bone mineral content (g) 6 months (pre and post intervention)
Secondary Change in Postural sway (mm) 6 months (pre and post intervention)
Secondary Change in Maximal hop height (mm) 6 months (pre and post intervention)
Secondary Change in Ground Reaction force Maximal Hop (N) 6 months (pre and post intervention)
Secondary Change in Ground Reaction force for a set of ten hops (N) 6 months (pre and post intervention)
Secondary Change in BMD(D100) (mg HA/cm3) Volumetric Bone mineral density 6 months (pre and post intervention)
Secondary Change in Total bone mass (mg) 6 months (pre and post intervention)
Secondary Change in BV/TV (%) Percent bone volume 6 months (pre and post intervention)
Secondary Change in pBV/TV (%) Plate bone volume fraction 6 months (pre and post intervention)
Secondary Change in rBV/TV (%) Rod bone volume fraction 6 months (pre and post intervention)
Secondary Change in pBV/rBV (%) Plate to - rod ratio 6 months (pre and post intervention)
Secondary Change in pBV/BV (%) Plate tissue fraction 6 months (pre and post intervention)
Secondary Change in rBV/BV (%) Rod tissue fraction 6 months (pre and post intervention)
Secondary Change in Bone surface(BS) (mm2) 6 months (pre and post intervention)
Secondary Change in BS/TV (mm-1) Bone surface density 6 months (pre and post intervention)
Secondary Change in Tb.Th (mm) Trabecular thickness 6 months (pre and post intervention)
Secondary Change in Tb.Sp (mm) Trabecular Separation 6 months (pre and post intervention)
Secondary Change in Tb.N (mm-1) Trabecular number 6 months (pre and post intervention)
Secondary Change in Tb.Pf Trabecular bone pattern (Tb.PF) follows the course of stress lines in the bone. This measurement indicates where the bone is under increased stress. 6 months (pre and post intervention)
Secondary Change in Conn.D (mm-3) Connectivity density 6 months (pre and post intervention)
Secondary Change in DA Degree of anisotropy 6 months (pre and post intervention)
Secondary Change in t Tortuosity (t) is a measure of how well a structure can curve and bend easily. This is an indicator of where the most stress is on the bone structure. 6 months (pre and post intervention)
Secondary Change in SMI Structural model index 6 months (pre and post intervention)
Secondary Change in BRV (mm3) Bone resorption volume 6 months (pre and post intervention)
Secondary Change in BFV (mm3) Bone formation volume 6 months (pre and post intervention)
Secondary Change in BRM (mg) Bone resorption mass 6 months (pre and post intervention)
Secondary Change in BFM (mg) Bone formation mass 6 months (pre and post intervention)
Secondary Change in BRF (%) Bone resorption fraction 6 months (pre and post intervention)
Secondary Change in BFF(%) Bone formation fraction 6 months (pre and post intervention)
Secondary Change in BRR(mm3/week) Bone resorption rate 6 months (pre and post intervention)
Secondary Change in BFR(mm3/week) Bone formation rate 6 months (pre and post intervention)
Secondary Change in Trabecular orientation distribution (Tb.O.D) (angle in degrees) This is a measurement of the orientation of the trabeculae in the distal tibia relative to the central axis tibial shaft. The orientation can be categorised into transvers direction and longitudinal direction along the tibial shaft 6 months (pre and post intervention)
Secondary Change in Ct.Th(mm) Cortical thickness 6 months (pre and post intervention)
Secondary Change in B.Po(%) Bone porosity 6 months (pre and post intervention)
Secondary Change in Po.Dm(mm) Pore diameter 6 months (pre and post intervention)
Secondary Change in Pore volume distribution 6 months (pre and post intervention)
Secondary Change in Failure load (N) 6 months (pre and post intervention)
Secondary Change in Strain This analyses the change in length of the bone over the time period, expressed as % change. 6 months (pre and post intervention)
Secondary Change in Stiffness (N/mm) 6 months (pre and post intervention)
Secondary Change in Young's Modulus (GPa) 6 months (pre and post intervention)
Secondary Change in Mechanical anisotropic ratio 6 months (pre and post intervention)
Secondary Change in Strain energy density (J/m3) 6 months (pre and post intervention)
Secondary Change in Strain gradient (µe/mm) 6 months (pre and post intervention)
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Completed NCT03037489 - A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients Phase 2